Survival analysis to assess of the effectiveness of fecal microbiota transplantation for recurrent and/or refractory Clostridioides difficile infection

Introduction Clostridioides difficile (C. difficile) infection (CDI) commonly occurs as a complication of antibiotic therapy. The healthy bacteria that reside within the colon are the major defense against the growth of C. difficile within the large intestine. Use of antibacterial medications facilitates the emergence of bacterial populations, causing the disruption of